Respirology Search
Respirology Respirology
rhinitis%20-%20nonallergic
RHINITIS - NONALLERGIC
Nonallergic rhinitis is the inflammation of the nasal lining membranes without any immunoglobulin E mediation, as documented by allergen skin testing.
Major signs and symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Symptoms can reverse spontaneously with or without treatment.

Rhinitis - Nonallergic Drug Information

Drug Information

Indication: Symptomatic treatment of seasonal & perennial allergic rhinitis.

Indication: Symptomatic relief of nasal & nasopharyngeal congestion. Facilitates intranasal exam or before nasal surge...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhi...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold including nasal congestion, sneezing, rhi...

Indication: Seasonal allergic & allergic/non-allergic perennial rhinitis. Treatment or prevention of nasal polyps afte...

Indication: Prophylaxis & chronic treatment of asthma. Symptomatic relief of day- & nighttime seasonal allergic rh...

Indication: Prophylaxis & chronic treatment of asthma. Symptomatic relief of daytime & nighttime seasonal allergic...

Aerius D-12
desloratadine + pseudoephedrine sulphate

Indication: Symptomatic relief of nasal & non-nasal allergic rhinitis including nasal congestion in adults & child...

Indication: Relief of symptoms associated w/ allergic rhinitis & common cold eg, nasal congestion, sneezing, rhinorrhe...

Indication: Symptomatic treatment of perennial & seasonal allergic rhinitis, vasomator rhinitis, allergic conjunctivit...

1  /  8
1  /  8
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Gefapixant cuts frequency of chronic coughs in 2 large studies
Pearl Toh, 4 days ago
Gefapixant, a first-in-class non-narcotic, oral P2X3 receptor antagonist, significantly reduces cough frequency in patients with refractory or unexplained chronic cough, according to two COUGH* studies presented at ERS 2020.
Diabesity and COVID-19: A critical combination
Roshini Claire Anthony, 18 Jul 2020

The concurrent occurrence of diabesity and COVID-19 may lead to more severe disease due to the latter, according to a presentation at the Opening Session of ENDO Online.
How to ward off medication errors: Experts' perspectives
Pearl Toh, 18 Jan 2020
Almost three-quarters of adverse events (AEs) related to medication errors in over-the-counter (OTC) cough and cold medications (CCMs) for paediatrics required evaluation by healthcare facility and majority of the cases were due to dosing errors, a surveillance study has found, highlighting the need for interventions to mitigate medication errors.
Mepolizumab: Targeting eosinophils in severe asthma with precision medicine
Pearl Toh, 6 days ago
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.